MN Healthcare

1. Product Name
Salbutamol Inhaler IP 100 mcg

2. Generic Name
Salbutamol

3. Strength (mg per tablet/capsule)
100 micrograms per actuation

4. Dosage Form
Metered Dose Inhaler (MDI)

5. Therapeutic / Pharmacological Class
Short-Acting Beta-2 Adrenergic Agonist (SABA) / Bronchodilator

6. Description (what it is & how it works)
Salbutamol Inhaler IP is a fast-acting bronchodilator used to relieve bronchospasm in respiratory conditions. Salbutamol selectively stimulates beta-2 adrenergic receptors in the bronchial smooth muscle, causing relaxation of airway muscles and widening of the airways. This improves airflow and makes breathing easier. The inhaled route delivers the medicine directly to the lungs for rapid onset of action.

7. Prescribed For / Uses

• Relief of acute bronchospasm

• Bronchial asthma

• Chronic obstructive pulmonary disease (COPD)

• Exercise-induced bronchoconstriction

• Wheezing and shortness of breath

8. Also Contains (Inactive Excipients – general, not brand-specific)

• Propellants (HFA-based)

• Ethanol (if applicable)

• Surfactants

• Valve and canister components

9. Packaging Type (blister / alu-alu / bottle – general)
Pressurized canister with actuator and mouthpiece

10. Shelf Life (standard pharma range)
24 months from the date of manufacture

11. Used By (Men / Women / Both / Adults only)
Men, Women, and Children (as prescribed)

12. Usage / Application (Personal / Clinical / Hospital)
Personal, Clinical, and Hospital use

1. Product Name
Budesonide Formoterol Inhalation Powder 320 µg

2. Generic Name
Budesonide & Formoterol Fumarate

3. Strength (mg per tablet/capsule)
As per label claim (320 µg Budesonide with corresponding Formoterol per inhalation)

4. Dosage Form
Inhalation Powder (Dry Powder Inhaler)

5. Therapeutic / Pharmacological Class
Corticosteroid + Long-Acting Beta-2 Agonist (LABA); Antiasthmatic / Bronchodilator

6. Description (what it is & how it works)
Budesonide Formoterol Inhalation Powder is a fixed-dose combination used for the management of obstructive airway diseases. Budesonide is an inhaled corticosteroid that reduces airway inflammation, swelling, and mucus production. Formoterol is a long-acting beta-2 agonist that relaxes bronchial smooth muscle, leading to sustained bronchodilation. Together, they improve breathing, reduce symptoms, and help prevent exacerbations when used regularly as prescribed.

7. Prescribed For / Uses

• Bronchial asthma

• Chronic obstructive pulmonary disease (COPD)

• Prevention of asthma symptoms and exacerbations

• Maintenance therapy for airway inflammation and bronchoconstriction

8. Also Contains (Inactive Excipients – general, not brand-specific)
Carrier particles (such as lactose), stabilizers, and approved inhalation-grade excipients

9. Packaging Type (blister / alu-alu / bottle – general)
Dry powder inhaler device with blister strips or capsule-based system

10. Shelf Life (standard pharma range)
24 to 36 months from the date of manufacture

11. Used By (Men / Women / Both / Adults only)
Both (Adults only, unless otherwise prescribed)

12. Usage / Application (Personal / Clinical / Hospital)
Personal, Clinical, Hospital

1. Product Name
Formoterol Fumarate and Budesonide Inhaler

2. Generic Name
Formoterol Fumarate & Budesonide

3. Strength (mg per tablet/capsule)
As per label claim (expressed as micrograms per actuation/inhalation)

4. Dosage Form
Inhaler (Metered Dose Inhaler or Dry Powder Inhaler)

5. Therapeutic / Pharmacological Class
Corticosteroid + Long-Acting Beta-2 Agonist (LABA); Antiasthmatic / Bronchodilator

6. Description (what it is & how it works)
Formoterol Fumarate and Budesonide Inhaler is a fixed-dose combination used for maintenance treatment of obstructive airway diseases. Budesonide is an inhaled corticosteroid that reduces airway inflammation, swelling, and mucus secretion. Formoterol fumarate is a long-acting beta-2 agonist that relaxes bronchial smooth muscle, producing sustained bronchodilation. Together, they improve airflow, control symptoms, and help prevent disease exacerbations when used regularly.

7. Prescribed For / Uses

• Bronchial asthma

• Chronic obstructive pulmonary disease (COPD)

• Maintenance therapy for airway inflammation

• Prevention of asthma and COPD exacerbations

8. Also Contains (Inactive Excipients – general, not brand-specific)
Propellants or carrier particles (such as lactose), stabilizers, and approved inhalation-grade excipients

9. Packaging Type (blister / alu-alu / bottle – general)
Inhaler device (MDI canister or DPI with blister strips/capsules)

10. Shelf Life (standard pharma range)
24 to 36 months from the date of manufacture

11. Used By (Men / Women / Both / Adults only)
Both (Adults only, unless otherwise prescribed)

12. Usage / Application (Personal / Clinical / Hospital)
Personal, Clinical, Hospital